News Detail

New Delhi, 22 Feb 2025: The Appointments Committee of the Cabinet (ACC) has approved an extension of tenure for Rajeev Singh Raghuvanshi as Drug Controller General of India (DCGI) for a one-year term.
Raghuvanshi, who took charge as DCGI on February 23, 2023, was......
View Details
Source : Business Standard
Rajeev Singh Raghuvanshi
DCGI
Drug Controller General of India
health regulatory
healthcare
Health Ministry
Related News
- Export NOCs, permission to manufacture and not approved by the importing country for combination of Tapentadol and Carisoprodol are revoked (22-02-2025)
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- CrisprBits develops PathCrisp for detection of AMR (22-02-2025)
- Medicines valued at Rs 2 lakh confiscated from Hans Foundation Chhabra office (21-02-2025)